Phase II clinical trial - Gynécologie - Endomètre
UTOLA
Gynécologie - Endomètre
Essai clinique fermé
Public cible
Adulte
Multicenter Double Blind Randomized Phase II Trial of Olaparib vs Placebo as Maintenance Therapy in Platinum-sensitive Advanced Endometrial Carcinoma.
Description de l'essai
This is a phase IIB, national, randomized, double-blinded, comparative, multi-center study, to assess the efficacy of Olaparib as maintenance after a platinum based chemotherapy in patients with Advanced or metastatic endometrial cancer
Liens utiles
MANUEL RODRIGUES
Investigateur principal